For which renal tumors contrast enhanced ultrasonography is preferred and sufficient imaging method for diagnosis

Author(s):  
T Tsocheva ◽  
R Djerassi
Urology ◽  
2015 ◽  
Vol 86 (6) ◽  
pp. 1174-1178 ◽  
Author(s):  
Christopher B. Allard ◽  
Alexander Coret ◽  
Shawn Dason ◽  
Camilla Tajzler ◽  
Bobby Shayegan ◽  
...  

2003 ◽  
Vol 29 (5) ◽  
pp. S139
Author(s):  
M. Takahashi ◽  
T. Hirai ◽  
H. Ohishi ◽  
E. Tokuno ◽  
E. Hussain ◽  
...  

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Jian-Chao Zhang ◽  
Hui-Xia Lan ◽  
Hui-Juan Zhao ◽  
Yang-Yang Lei ◽  
Li Ma ◽  
...  

Abstract Background Post-transplant lymphoproliferative disorders (PTLDs) represent a spectrum of heterogenetic lymphoid proliferations. PTLD is a serious complication that affects the long-term survival of kidney transplant patients. Imaging examination is an important method for detecting and diagnosing PTLD. Contrast-enhanced ultrasonography (CEUS) and CEUS-guided biopsy are important modalities for tumor detection and diagnosis. In this case, we describe a 69 years old man in whom a native kidney PTLD was confirmed by CEUS. Case presentation A 69-year-old male patient who had a kidney transplant 1 year earlier presented with 3 months of progressive myasthenia of both lower limbs associated with amyotrophy and weight loss. Although positron emission tomography/computed tomography (PET-CT) showed a high metabolic lesion in the untransplanted kidney, abdominal contrast enhanced computed tomography cannot detect the lesion in the atrophic left kidney. The above examinations showed that the transplanted kidney was normal. CEUS can detect a homogeneously enhanced lesion in the same location as PET-CT. Subsequently, a biopsy was performed under CEUS guidance, and the final pathological diagnosis was diffuse large B-cell lymphoma. The patient then received the R-CHOP treatment. Unfortunately, pulmonary thromboembolism occurred 2 weeks later, and the patient’s condition was not alleviated through active treatment. Finally, the patient’s family gave up treatment, and the patient was discharged. Conclusion The case suggested that CEUS was a valuable imaging method for patient with renal transplantation to detect and diagnose of PTLD.


2005 ◽  
Vol 24 (12) ◽  
pp. 1635-1640 ◽  
Author(s):  
Hideyuki Tamai ◽  
Yoshie Takiguchi ◽  
Masashi Oka ◽  
Naoki Shingaki ◽  
Shotaro Enomoto ◽  
...  

2021 ◽  
Vol 11 (2) ◽  
pp. 81
Author(s):  
Ioana Boca (Bene) ◽  
Sorin M. Dudea ◽  
Anca I. Ciurea

The aim of this paper is to highlight the role of contrast-enhanced ultrasound in breast cancer in terms of diagnosis, staging and follow-up of the post-treatment response. Contrast-enhanced ultrasound (CEUS) is successfully used to diagnose multiple pathologies and has also clinical relevance in breast cancer. CEUS has high accuracy in differentiating benign from malignant lesions by analyzing the enhancement characteristics and calculating the time-intensity curve’s quantitative parameters. It also has a significant role in axillary staging, especially when the lymph nodes are not suspicious on clinical examination and have a normal appearance on gray-scale ultrasound. The most significant clinical impact consists of predicting the response to neoadjuvant chemotherapy, which offers the possibility of adjusting the therapy by dynamically evaluating the patient. CEUS is a high-performance, feasible, non-irradiating, accessible, easy-to-implement imaging method and has proven to be a valuable addition to breast ultrasound.


Sign in / Sign up

Export Citation Format

Share Document